|
[1] ZHANG HB,WANG Y. Research progress of non-alcoholic fatty liver disease[J]. Hainan Med,2017,28(10):1651-1653.(in Chinese)张海博,王宇.非酒精性脂肪肝的现代研究进展[J].海南医学,2017,28(10):1651-1653.
|
|
[2] SHE QM,MAO H. Research progress of the relationship between gut microbiome and chronic liver diseases[J]. World J complex Med,2019,5(3):163-165.(in Chinese)佘秋敏,毛华.肠道菌群与慢性肝脏疾病关系的研究进展[J].世界复合医学,2019,5(3):163-165.
|
|
[3] WANG K,LI JT,YAN SG,et al. Effects of intestinal microecology on malignant transformation of liver cirrhosis-liver precancerous lesion[J]. Chin J Gastroenterol Hepatol,2018,27(1):111-114.(in Chinese)王轲,李京涛,闫曙光,等.肠道微生态对肝硬化-肝癌癌前病变恶性转变的影响[J].胃肠病学和肝病学杂志,2018,27(1):111-114.
|
|
[4] LI XL,SUN FX,SUI JL,et al. Association between gut microbiota and cholestasis[J]. Chin J Integr Trad West Med Dig,2016,24(11):886-887,890.李晓玲,孙凤霞,隋京利,等.肠道微生态与胆汁淤积的关系[J].中国中西医结合消化杂志,2016,24(11):886-887,890.
|
|
[5] MINEMURA M,SHIMIZU Y. Gut microbiota and liver diseases[J]. World J Gastroenterol,2015,21(6):1691-1702.
|
|
[6] HAN ML,GONG ZH. Mechanism of action of gut microbiota in hepatobiliary diseases[J]. J Clin Hepatol,2017,33(2):384-388.(in Chinese)韩美林,龚振华.肠道菌群在肝胆疾病中的作用机制[J].临床肝胆病杂志,2017,33(2):384-388.
|
|
[7] STALEY C,WEINGARDEN AR,KHORUTS A,et al. Interaction of gut microbiota with bile acid metabolism and its influence on disease states[J]. Appl Microbiol Biotechnol,2017,101(1):47-64.
|
|
[8] ZHAO L. Change in Paneth cells in the intestinal epithelium and its association with intestinal mucosal barrier in rats with obstructive jaundice[D]. Binzhou:Binzhou Medical University,2016.(in Chinese)赵亮.梗阻性黄疸大鼠肠粘膜上皮潘氏细胞变化及其与肠粘膜屏障的关系[D].滨州:滨州医学院,2016.
|
|
[9] ZHANG LJ. HO-1/CO repairs intestinal barrier injury in cholestasis and liver injury by regulating TLR4/NF-κB[D]. Dalian:Dalian Medical University,2017.(in Chinese)张丽静. HO-1/CO通过调控TLR4/NF-κB修复胆汁淤积肝损伤肠屏障破坏的研究[D].大连:大连医科大学,2017.
|
|
[10] MA WP. Effect of internal and external bile drainage on the expression of MUC2 protein in the intestinal mucosa in rats with obstructive jaundice[D]. Shijiazhuang:Hebei Medical University,2016.(in Chinese)马伟平.胆汁内外引流术对梗阻性黄疸大鼠肠黏膜MUC2蛋白表达的影响[D].石家庄:河北医科大学,2016.
|
|
[11] SIPKA S,BRUCKNER G. The immunomodulatory role of bileacids[J]. Clin Gastroenterol,2015,49(1):s69-s73.
|
|
[12] SARAC F,SALMAN T,GUN F,et al. Effect of probiotic supplemen-tation on bacterial translocation in common bile duct obstruc-tion[J]. Pediatr Surg Int,2015,31(2):155-161.
|
|
[13] GUO S,SHU SN. Application of probiotics in children with hepatobiliary diseases[J]. Chin J Pract Pediatr,2017,32(2):110-114.(in Chinese)郭珊,舒赛男.益生菌在儿童肝胆疾病的应用[J].中国实用儿科杂志,2017,32(2):110-114.
|
|
[14] KO MT,HUANG HC,LEE WS,et al. Metformin reduces intrahepatic fibrosis and intrapulmonary shunts in biliary cirrhotic rats[J]. J Chin Med Assoc,2017,80(8):467-475.
|
|
[15] YANG L,CAO Y,YANG CQ. Pathogenesis and related diseases of cholestasis[J]. J Intern Med Concepts Pract,2014,9(5):308-312.(in Chinese)杨丽,曹燕,杨长青.胆汁淤积的发生机制及相关疾病[J].内科理论与实践,2014,9(5):308-312.
|
|
[16] HUANG JR. Interpretation of the expert consensus on the diagnosis and treatment of intrahepatic cholestasis[J/CD].Chin J Front Med Sci:Electronic Version,2016,8(3):9-11.(in Chinese)黄建荣.肝内胆汁淤积症诊治专家共识解读[J/CD].中国医学前沿杂志:电子版,2016,8(3):9-11.
|
|
[17] CHAPMAN R,CULLEN S. Etiopathogenesis of primary sclerosing cholangitis[J]. World J Gastroenterol,2008,14(21):3350-3359.
|
|
[18] LIU XJ. Clinical effect of S-adenosylmethionine in treatment of viral hepatitis with intrahepatic cholestasis[J]. J Clin Med,2015,2(27):5736.(in Chinese)刘现军.腺苷蛋氨酸治疗肝内胆汁淤积性病毒性肝炎疗效观察[J].临床医药文献杂志,2015,2(27):5736.
|
|
[19] JNGST C,BERG T,CHENG J,et al. Intrahepatic cholestasis in common chronic liver diseases[J]. Eur J Clin Invest,2013,43(10):1069-1083.
|
|
[20] WANG XL,WANG L,JIANG XH. Protective effect of anethol trithione against drug-induced liver injury due to rifampicin and related mechanism[J]. West China J Pharm Sci,2018,33(5):501-503.(in Chinese)叶晓莉,王凌,蒋学华.茴三硫对利福平致药物性肝损伤的保护作用及机制[J].华西药学杂志,2018,33(5):501-503.
|
|
[21] CHEN J,WANG JL,MA GW. Studyon characteristics and mechanism of liver function damaged in using simvastatin combined with HRZ[J]. Anti Infect Pharm,2016,13(4):729-735.(in Chinese)陈洁,王俊龙,马国伟.抗结核药与辛伐他汀联用致肝损伤的特征及其机制研究[J].抗感染药学,2016,13(4):729-735.
|
|
[22] XIE JF,WANG YQ,YUAN CG. Research advances in the role of bile acid,gut microbiota,and their interaction in liver regeneration[J]. J Hepatol Pan Surg,2018,30(1):87-89.(in Chinese)谢经丰,王永芹,袁晟光.胆汁酸与肠道菌群及其相互影响在肝再生中的作用研究进展[J].肝胆胰外科杂志,2018,30(1):87-89.
|
|
[23] LECHUGA S,IVANOV AI. Disruption of the epithelial barrier during intestinal inflammation:Quest for new molecules and mechanisms[J]. Biochim Biophys Acta Mol Cell Res,2017,1864(7):1183-1194.
|
|
[24] ODENWALD MA,CHOI W,KUO WT,et al. The scaffolding protein ZO-1 coordinates actomyosin and epithelial apical specializations in vitro and in vivo[J]. J Biol Chem,2018,293(45):17317-17335.
|
|
[25] ZIHNI C,MILLS C,MATTER K,et al. Tight junctions:From simple barriers to multifunctional molecular gates[J]. Nat Rev Mol Cell Biol,2016,7(9):564-580.
|
|
[26] ABUFADDAN NH,SHERIF TM,MOHAMMED OA,et al. Intestinal barrier integrity and function in infants with cholestasis[J]. Intest Res,2017,15(1):118-123.
|
|
[27] TANAKA K,NAKAMURA Y,TERAHARA M,et al. Poor bifidobacterial colonization is associated with late provision of colostrum and improved with probiotic supplementation in low birth weight infants[J]. Nutrients,2019,11(4):839.
|
|
[28] SONG JC,GAO H,QIU HB,et al. The pharmacokinetics of dexmedetomidine in patients with obstructive jaundice:A clinical trial[J]. PLo S One,2018,13(11):e0207427.
|
|
[29] CAVE MC,CLAIR HB,HARDESTY JE,et al. Nuclear receptors and nonalcoholic fatty liver disease[J]. Biochim Biophys Acta,2016,1859(9):1083-1099.
|
|
[30] CARIELLO M,PICCININ E,GARCIA-IRIGOYEN O,et al.Nuclear receptor FXR,bile acids and liver damage:Introducing the progressive familial intrahepatic cholestasis with FXR mutations[J]. Biochim Biophys Acta Mol Basis Dis,2018,1864(4):1308-1318.
|
|
[31] WANG J,FU T,DONG R,et al. Hepatoprotection of auraptene from the peels of citrus fruits against 17alpha-ethinylestradiol-induced cholestasis in mice by activating farnesoid X receptor[J]. Food Funct,2019,10(7):3839-3850.
|
|
[32] SCHMITT J,KONG B,STIEGER B,et al. Protective effects of farnesoid X receptor(FXR)on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15signal[J]. Liver Int,2015,35(4):1133-1144.
|
|
[33] XIONG XL,DING Y,CHEN ZL,et al. Emodin rescues intrahepatic cholestasis via stimulating FXR/BSEP pathway in promoting the canalicular export of accumulated bile[J]. Front Pharmacol,2019,10:522.
|
|
[34] FRIEDMAN ES,LI Y,SHEN TD,et al. FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid[J]. Gastroenterology,2018,155(6):1741-1752.
|
|
[35] ALAMDARY SZ,BAKHSHI B,SOUDI S. The anti-apoptotic and anti-inflammatory effect of Lactobacillus acidophilus on Shigella sonnei and Vibrio cholerae interaction with intestinal epithelial cells:A comparison between invasive and non-invasive bacteria[J]. PLo S One,2018,13(6):e196941.
|
|
[36] VANDER HJ,GOLDSTONE RJ,HARRIS S,et al. Substantial extracellular metabolic differences found between phylogenetically closely related probiotic and pathogenic strains of escherichia coli[J]. Front Microbiol,2019,10:252.
|
|
[37] CORSELLO G,CARTA M,MARINELLO R,et al. Preventive effect of cow’s milk fermented with lactobacillus paracasei CBA L74 on common infectious diseases in children:A multicenter randomized controlled trial[J]. Nutrients,2017,9(7):669.
|
|
[38] MIR H,MEENA AS,CHAUDHRY KK,et al. Occludin deficiency promotes ethanol-induced disruption of colonic epithelial junctions,gut barrier dysfunction and liver damage in mice[J]. Biochim Biophys Acta,2016,1860(4):765-774.
|
|
[39] JIN PF. Effect of probiotics on lipopolysaccharide-induced liver injury and expression of inflammatory factors in mice and related mechanism[D]. Hangzhou:Zhejiang University,2015.(in Chinese)金鹏锋.益生菌对LPS诱导的小鼠肝损伤和炎症因子表达的影响作用及机制研究[D].杭州:浙江大学,2015.
|
|
[40] SHUKLA PK,GANGWAR R,MANDA B,et al. Rapid disruption of intestinal epithelial tight junction and barrier dysfunction by ionizing radiation in mouse colon in vivo:protection by Nacetyl-l-cysteine[J]. Am J Physiol Gastrointest Liver Physiol,2016,310(9):g705-g715.
|
|
[41] YANG R,HARAD T,LI J,et al. Bile modulates intesinal epithelial barrier function via an racellular signal related kinase 1/2dependent mechanism[J]. Intensive Care Med,2005,31(5):709-717.
|
|
[42] ASSIMAKOPOULOS SF,SCOPA CD,CHARONIS A,et al. Experimental obstructive jaundice disrupts intestinal mucosal barrier by altering occludin expression:Beneficial effect of bombesin and neurotensin[J]. J Am Col Surg,2004,198(5):748-757.
|
|
[43] WANG T,ZHOU ZX,et al. Resveratrol effectively attenuates alpha-naphthyl isothiocyanate-induced acute cholestasis and liver injury through choleretic and anti-inflammatory mechanisms[J]. Acta Pharmacol Sin,2014,35(12):1527-1536.
|
|
[44] SABINO J,VIEIRA-SILVA S,MACHIELS K,et al. Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD[J]. Gut,2016,65(10):1681-1689.
|
|
[45] DENEAU M,PERITO E,RICCIUTO A,et al. Ursodeoxycholic acid therapy in pediatric primary sclerosing cholangitis:Predictors of gamma glutamyltransferase normalization and favorable clinical course[J]. J Pediatr,2019,209:92-96.
|
|
[46] IWASAWA K,SUDA W,TSUNODA T,et al. Characterisation of the faecal microbiota in Japanese patients with paediatriconset primary sclerosing cholangitis[J]. Gut,2017,66(7):1344-1346.
|
|
[47] BAJAJ JS,KAKIYAMA G,ZHAO D,et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gutliver axis[J]. Alcohol Clin Exp Res,2017,41(11):1857-1865.
|
|
[48] SAKAI F,HOSOYA T,ONO-OHMACHI A,et al. Lactobacillus gasseri SBT2055 induces TGF-beta expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine[J]. PLo S One,2014,9(8):e105370.
|
|
[49] NOGACKA AM,ODDI S,SALAZAR N,et al. Intestinal immunomodulation and shifts on the gut microbiota of BALB/c mice promoted by two bifidobacterium and lactobacillus strains isolated from human samples[J]. Biomed Res Int,2019,2019:2323540.
|
|
[50] KENNEDY L,FRANCIS H,INVERNIZZI P,et al. Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis[J]. FASEB J,33(9):10269-10279.
|
|
[51] XU HB. Clinical effect of S-adenosylmethionine combined with glucocorticoids in treatment of drug-induced cholestatic liver disease[J]. Guide Chin Med,2018,16(3):118-119.(in Chinese)徐洪滨.腺苷蛋氨酸联合糖皮质激素治疗药物性胆汁淤积性肝病的疗效研究[J].中国医药指南,2018,16(3):118-119.
|
DownLoad: